Severe Obesity Management in a Large Academic Health System: A Retrospective Evaluation of Metabolic Bariatric Surgery Counselling Practices [0.03%]
大型学术医疗系统中重度肥胖管理的回顾性评估：代谢代谢手术咨询实践的回顾性评价
Mustafa Naveed,Elizabeth Gienger,Tonja Locklear et al.
Mustafa Naveed et al.
Metabolic and bariatric surgery (MBS) is an effective treatment for severe obesity but remains substantially underutilized. Limited data exist on outpatient counselling patterns preceding surgical uptake. Using electronic health record data...
Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health-Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial [0.03%]
利拉鲁肽对肥胖伴慢性阻塞性肺病患者的阻塞性睡眠呼吸暂停及生活质量影响的探索性分析：一项随机对照试验的事后分析
Sofie Krogh Wolsing,Ayse Dudu Altintas Dogan,Claus Bogh Juhl et al.
Sofie Krogh Wolsing et al.
Obstructive sleep apnea (OSA) is associated with chronic obstructive pulmonary disease (COPD) and obesity, and all three are linked to reduced health-related quality of life (HRQoL). Coexistence of OSA and COPD increases morbidity and morta...
Randomized Controlled Trial
Clinical obesity. 2026 Apr;16(2):e70079. DOI:10.1111/cob.70079 2026
Misconceptions About Obesity and Weight Stigma in Brazilian Healthcare Professionals [0.03%]
巴西医疗专业人员对肥胖的误解和体重歧视
Paula Victoria Sozza,Eva Penelo,Stuart William Flint et al.
Paula Victoria Sozza et al.
People living with obesity (PLWO) frequently experience weight stigma (WS) in healthcare settings, leading to disparities in treatment. Although research shows that healthcare professionals (HCPs) often hold stigmatising views, this issue r...
Comparison of Semaglutide and Lifestyle Counselling for Weight Loss Using Multi-Site Electronic Health Records [0.03%]
利拉鲁肽与生活习惯指导的减重效果对比研究——基于多中心电子健康档案数据的分析
William J B Powell,Diego R Mazzotti,Stephen D Herrmann et al.
William J B Powell et al.
To evaluate the effectiveness of semaglutide compared with lifestyle counselling alone for weight loss in diabetic and non-diabetic patients with obesity. This multi-site, retrospective, observational study uses data from electronic health ...
Observational Study
Clinical obesity. 2026 Apr;16(2):e70076. DOI:10.1111/cob.70076 2026
GLP-1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and BMI on Subsequent General Surgical Procedures [0.03%]
GLP-1受体激动剂与代谢手术：减重和BMI对后续普外科手术的影响如何？
Shahzaib Zindani,Selamawit Woldesenbet,Abdullah Altaf et al.
Shahzaib Zindani et al.
Obesity and T2DM substantially increase postoperative risk, with higher surgical site infections in obesity and up to a 65% increase in overall complications in T2DM. This study assesses the impact of weight loss interventions-metabolic bar...
A Randomised Feasibility Study Assessing Acute Physiological Responses to Weight Stigma in Women Living With Obesity [0.03%]
一项针对肥胖女性的体重歧视急性生理反应的随机可行性研究
Adrian Brown,Jed Wingrove,Stuart W Flint
Adrian Brown
Experimental evidence indicates that exposure to weight stigma can lead to sustained elevations in cortisol and ambulatory blood pressure. However, little is known about its acute effects on other physiological markers. This study aimed to ...
Randomized Controlled Trial
Clinical obesity. 2026 Apr;16(2):e70073. DOI:10.1111/cob.70073 2026
Burden of Obesity in India: Need for Policy Changes to Attain Highest Possible Level of Health and Well-Being [0.03%]
印度肥胖问题及其政策应对措施：实现尽可能高的健康和福祉水平
Sanjay Kalra,Jothydev Kesavadev,Ramen Goel et al.
Sanjay Kalra et al.
The rise in obesity rates in India in the past 3-4 decades is alarming and obesity management needs transformation. A significant barrier is that obesity is often viewed in India as a lifestyle condition rather than a chronic disease, despi...
Class III Obesity as a Presenting Syndrome in Prolactinoma Patients: Insights Into Obesity and Metabolic Dysfunction in This Unique Group [0.03%]
垂体泌乳素瘤患者的三期肥胖症的临床综合征特征——关于这一独特群体肥胖和代谢紊乱的新认识
Lukas Andereggen,Christoph Schmid,Michael Brändle et al.
Lukas Andereggen et al.
The occurrence of patients with lactotroph adenoma presenting with class III obesity is extremely rare. This study reports long-term outcomes of such patients treated with transsphenoidal surgery (TSS) or dopamine agonists (DAs) and integra...
Micronutrient and Nutritional Deficiencies Associated With GLP-1 Receptor Agonist Therapy: A Narrative Review [0.03%]
GLP-1受体激动剂治疗相关的微量元素及营养素缺乏：叙述性综述
Jorge Urbina,Luis Eduardo Salinas-Ruiz,César Valenciano et al.
Jorge Urbina et al.
Glucagon-like peptide-1 receptor agonists (GLP-1RA) such as semaglutide, liraglutide and tirzepatide are effective for obesity and type 2 diabetes mellitus (T2DM) but may predispose users to micronutrient deficiencies through appetite suppr...